Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT03868423
Title Brigatinib in Treating Patients With ALK and ROS1 Gene Alterations and Locally Advanced or Metastatic Solid Cancers
Recruitment Withdrawn
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Sameek Roychowdhury
Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST